Levent Celik

Levent Celik

Auto-generated profile, based on publicly available information

Levent Celik

Department of Radiology, Radiologica Imaging and Diagnostic Center, İstanbul 34846, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2019 in European Journal of Breast Health
Verified
Journal Article
Closed access
GGGozde gunes
Gozde gunes
CYCem Yilmaz
Cem Yilmaz
LCLevent Celik
Levent Celik
RCRahmi Cubuk
Rahmi Cubuk
NTNuri Tasali
Nuri Tasali
We present a case with imaging artefacts on mammography and Magnetic Resonance Imaging (MRI) caused by iron oxide particles. After being diagnosed with the medullary cancer of the breast, the female patient had a breast conserving surgery on right breast. Iron oxide particles were used for the detection of the sentinel lymph node during operation. On follow ups, a de novo density on mammography, which was initially thought to be a new tumour, was found. MR images proved that the lesion is an artefact caused by iron oxide accumulation. Our aim in this case study is to underline and discuss the imaging artefacts caused by these particles and raise awareness.

1 July 2023 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
AOAyşenur Oktay
Ayşenur Oktay
ÖAÖzge Aslan
Özge Aslan
FTFüsun Taşkın
Füsun Taşkın
NTNermin Tuncbilek
Nermin Tuncbilek
GIGul ESEN ICTEN
Gul ESEN ICTEN
NÖNecmettin Özdemir
Necmettin Özdemir
The clinical management of high-risk lesions using image-guided biopsy is challenging. This study aimed to evaluate the rates at which such lesions were upgraded to malignancy and identify possible predictive factors for upgrading high-risk lesions. This retrospective multicenter analysis included 1.343 patients diagnosed with high-risk lesions using an image-guided core needle or vacuum-assisted biopsy (VAB). Only patients managed using an excisional biopsy or with at least one year of documented radiological follow-up were included. For each, the Breast Imaging Reporting and Data System (BI-RADS) category, number of samples, needle thickness, and lesion size were correlated with malignancy upgrade rates in different histologic subtypes. Pearson's chi-squared test, the Fisher-Freeman-Halton test, and Fisher's exact test were used for the statistical analyses. The overall upgrade rate was 20.6%, with the highest rates in the subtypes of intraductal papilloma (IP) with atypia (44.7%; 55/123), followed by atypical ductal hyperplasia (ADH) (38.4%; 144/375), lobular neoplasia (LN) (12.7%; 7/55), papilloma without atypia (9.4%; 58/611), flat epithelial atypia (FEA) (8.7%; 10/114), and radial scars (RSs) (4.6%; 3/65). There was a significant relationship between the upgrade rate and BI-RADS category, number of samples, and lesion size Lesion size was the most predictive factor for an upgrade in all subtypes. ADH and atypical IP showed considerable upgrade rates to malignancy, requiring surgical excision. The LN, IP without atypia, pure FEA, and RS subtypes showed lower malignancy rates when the BI-RADS category was lower and in smaller lesions that had been adequately sampled using VAB. After being discussed in a multidisciplinary meeting, these cases could be managed with follow-up instead of excision.

21 October 2025 in BMC Surgery
Verified
Journal Article
Open access
PDF file
AGAdnan Gundogdu
Adnan Gundogdu
CWCeyda Sönmez Wetherilt
Ceyda Sönmez Wetherilt
AAAyhan Alpar
Ayhan Alpar
SASangar Abdullah
Sangar Abdullah
OYOsman Cem Yilmaz
Osman Cem Yilmaz
LCLevent Celik
Levent Celik
Ductal carcinoma in situ (DCIS) is a heterogeneous precursor lesion with variable invasive potential. Current predictive parameters for invasion risk offer limited utility for personalized assessment. This study aims to evaluate artificial intelligence (AI)-assisted mammography analysis as a tool for predicting invasion risk in DCIS patients. In this retrospective cohort study, 74 patients with pathologically proven DCIS by preoperative biopsy were analyzed using a deep learning-based AI system (Transpara version 1.7.4). The AI system classified patients into low-risk and high-risk groups, which were validated against postoperative histopathological findings. Statistical analysis included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy calculations. Invasion was detected in 19 (25.7%) patients, with 18 (94.7%) classified as high-risk by the AI system. The model demonstrated 94.7% sensitivity, 45.5% specificity, 37.5% PPV, and 96.2% NPV. In patients aged ≥ 50 years and those with lesions ≥ 3 cm, the NPV reached 100%. A significant relationship was found between necrosis and invasion (p = 0.004). The high NPV suggests AI-assisted mammography analysis could serve as an effective rule-out tool for invasion in DCIS patients, potentially identifying candidates for less aggressive surgical treatment. Further validation in larger, multi-center studies is necessary to confirm these findings.

21 August 2026 in Cancers
Verified
Journal Article
Open access
PDF file
OYOsman Cem Yılmaz
Osman Cem Yılmaz
AGAdnan Gundogdu
Adnan Gundogdu
MAMerve Aktaş
Merve Aktaş
KEKübra Ertekin
Kübra Ertekin
Merve TokoçinMerve Tokoçin
Merve Tokoçin
LÇLevent Çelik
Levent Çelik
Background/Objectives: Contralateral prophylactic mastectomy (CPM) is increasingly performed despite negative preoperative imaging. We evaluated the prevalence and MRI detectability of occult pathology in the contralateral breast. Methods: In this single-center retrospective cohort, 82 patients with unilateral invasive breast cancer underwent simultaneous CPM after preoperative contralateral MRI. Occult findings were classified as occult malignancy, atypical/high-risk lesions, or other lesions of uncertain malignant potential (B3 lesions); the primary outcome was clinically significant occult pathology (malignancy or an atypical/high-risk lesion). Proportions are reported with exact 95% confidence intervals and associations with exact odds ratios and Benjamini–Hochberg correction. Results: Occult malignancy occurred in 1/82 (1.2%; a single DCIS), clinically significant occult pathology in 14/82 (17.1%) and any occult pathology in 21/82 (25.6%). Among 59 patients with a negative MRI (BI-RADS 1–2), clinically significant occult pathology occurred in 18.6% and atypical/high-risk lesions in 16.9% (whole cohort, 15.9%). The single occult malignancy arose in an MRI-negative breast. No factor remained significant after correction for multiple comparisons. Conclusions: After preoperative MRI, occult malignancy is rare, whereas atypical and high-risk lesions frequently remain occult; a negative contralateral MRI excluded neither. These findings support individualized, shared decision-making rather than the yield of occult pathology as the basis for CPM.

3 May 2024 in The European Research Journal
Verified
Journal Article
Open access
PDF file
GKGökhan Karataş
Gökhan Karataş
OKOsman Kula
Osman Kula
NTNermin Tunçbi̇lek
Nermin Tunçbi̇lek
Objective: The purpose of this research is to compare the pre and post-radiotherapy mammograms of patients who had breast-conserving surgery (BCS) and radiotherapy to see how radiotherapy affects breast arterial calcifications (BAC). Methods: The study retrospectively compared the mammography examinations at least 24 months after radiotherapy and pre-radiotherapy mammography examinations of 123 female patients diagnosed with breast cancer and treated with BCS and radiotherapy between December 2001 and July 2011. Results: Breast arterial calcifications (BAC) increased statistically significantly in 25 patients who underwent radiotherapy after BCS. Conclusion: Our results indicate that BAC increases significantly after RT, especially in breasts treated with radiotherapy, with age being also a risk factor for BAC development.

20 August 2025 in BMC Surgery
Verified
Journal Article
Open access
PDF file
ITIksan Tasdelen
Iksan Tasdelen
AGAdnan Gundogdu
Adnan Gundogdu
KCKaan Celik
Kaan Celik
OYOsman Cem Yilmaz
Osman Cem Yilmaz
LCLevent Celik
Levent Celik
Background: Wire localization for nonpalpable breast lesions and pre-neoadjuvant chemotherapy (NAC) clips can lead to complications including wire migration, pneumothorax, and organ injury. This study evaluates the clinical efficacy and safety of a novel 3D-printed screw mechanism designed to prevent wire migration. Methods: This retrospective descriptive study included 104 patients with nonpalpable breast lesions and pre-NAC clips who underwent wire localization between March 2023 and August 2024. A screw mechanism was designed and manufactured using 3D printing technology with polylactic acid (PLA) material (4 g per device). The device features a 21.7 mm base diameter and elliptical wire hole (2.5 × 4 mm). Wire stability and complications were assessed through imaging and clinical follow-up. Results: The median age was 47 years (range: 33–82) and median BMI was 24.7 (17.9–40.8). Lesions were primarily located in the upper outer quadrant (49.9%). Among 68 patients receiving NAC, 44.1% achieved pathological complete response (ypT0N0). The screw mechanism successfully prevented wire migration during patient transport from radiology to operating room in all 104 cases (0% migration rate, 95% CI: 0-3.6%). No complications including pneumothorax, organ injury, or skin reactions were observed. The device was easily removed by simple unscrewing on the operating table before surgical skin preparation. Median device application time was 2–4 h. Conclusion: The 3D-printed screw mechanism effectively prevents wire migration and demonstrates excellent safety profile. Its simple design and ease of application make it a practical solution for improving patient safety during breast lesion localization procedures. Trial registration: Not applicable. This retrospective study did not require trial registration.